Galen Hope, a comprehensive eating disorder and mental health treatment program, announced the publication of a new study evaluating its Family Integration Model (FIM), a novel approach to involving ...

With GLP-1s readily available, some experts fear misuse is increasing and may be fueling eating disorders. Physicians describe what they are seeing and how they manage the risks.

With over 30% of eating disorder patients utilizing GLP-1 medications, experts urge primary care clinicians to screen for ...

Despite their prevalence, eating disorders (EDs) are under-researched and often misunderstood. A recent focus of research on the biological underpinnings of EDs has helped to reframe our understanding ...

In the last few decades, the prevalence of eating disorders (EDs), characterized by maladaptive eating behaviors such as extreme calorie restriction, binge-eating, and self-induced vomiting, has ...

GLP-1s significantly reduce appetite, slow digestion and promote weight loss.